Sommer S. Zimmerman, PhD

Patent Agent

zimmermans@ballardspahr.com
Tel 678.420.9450
Fax 678.420.9301
Atlanta

Sommer S. Zimmerman is a patent agent and a member of the chemical and pharmaceutical practice teams in Ballard Spahr's Patents Group. She is an inventor on a patent application for a novel class of compounds for the treatment of neurological conditions. Sommer has multidisciplinary experience collaborating with synthetic organic chemists, biologists, and pharmacologists. She received her Ph.D. in 2013 from Emory University in chemistry, with an emphasis in medicinal and organic chemistry.

Sommer serves as Co-Director of the Emerging Leaders Network's First Contact Program in Atlanta, matching young professionals, post-doctoral students, and graduate students with key industry leaders within the life sciences industry.

Most recently, Sommer interned with the Emory University Office of Technology Transfer. There, she authored technology briefs for potential out-licensing opportunities of Emory technologies and performed market analysis, including market size, potential licensees, and alternative markets for patented technologies. 

As a graduate research assistant within Emory's Department of Chemistry, Sommer developed and implemented multi-step synthetic routes to access a novel class of subunit selective potentiators of N-methyl-D-aspartate (NMDA) receptors. She also was responsible for maintaining and managing an electronic chemical inventory for 20 organic chemists.

Professional Activities

American Chemical Society (Organic and Medicinal Chemistry divisions), past member

Publications

Co-author, "NMDA Receptor Modulators: An Update," Expert Opinion on Therapeutic Patents, 2013

Co-author, "Subunit Selective NMDA Receptor Antagonists for the Treatment of Neurological Conditions," PCT/US Application

Co-author, "Consecutive Sigmatropic Rearrangements in the Enantioselective Total Synthesis of (-)-Joubertinamine and (-)-Mesembrine," Tetrahedron, 2009

Speaking Engagements

"Potentiation of the GluN2C Containing NMDA Receptors by Pyrrolidinones, a Novel Class of Compounds," Society for Neuroscience, New Orleans, October 13-17, 2012

"Design, Synthesis and Structure-Activity-Relationship of a Novel Series of GluN2C Selective Potentiators," Abstract of Papers, 244th American Chemical Society National Meeting, Philadelphia, August 19-23, 2012

"Potentiation of the GluN2C Containing NMDA Receptors by Pyrrolidinones, a Novel Class of Compounds," Postdoctoral Fellow Research Symposium, Emory University School of Medicine, Atlanta, May 31, 2012


Emory University (Ph.D. 2013, organic chemistry)

Florida State University (B.S. 2006; B.S. 2008, chemistry)

U.S. Patent and Trademark Office